CSI Market
Sign In | Register

Disc Medicine Inc (IRON) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access IRON Annual Cash Flow →
This cash flow overview for Disc Medicine Inc spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-123.04
Depreciation & amortization0.18
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation25.89
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Interest Expense Debt Excluding Amortization-
Induced Conversion Of Convertible Debt Expense-
Accretion Of Discount On Convertible Notes-
Change In Fairv Alue Of Derivative-
Noncash License Expense-
Noncash Lease Expense0.13
Increase Decrease In Operating Lease Liability-0.17
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-2.18
Increase (Decrease) in Other Accrued Liabilities-6.68
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.26
Other Working Capital0.00
Other Noncash Income (Expense)0.01
Other net1.56
Payments for (Proceeds from) Other Operating Activities-4.45
Discontinued operations0.00
Net Cash flow from Operating Activities-106.44
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities266.43
Payments to Acquire Marketable Securities-186.49
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities79.94
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings29.98
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.05
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Business Combination Net-
Principal Payments On Term Loan-
Cash Acquired In Connection With Reverse Recapitalization-
Payment Of Reverse Recapitalization Transaction Costs-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents91.39
Proceeds From Sale Of Common Stock In Offerings Net Of Issuance Costs Paid-
Proceeds From Sale Of Pre Funded Warrants In Offerings Net Of Issuance Costs Paid-
Proceeds From Sale Of Common Stock In Underwritten Offering Net Of Issuance Costs Paid-
Proceeds From Sale Of Pre Funded Warrants In Underwritten Offerings Net Of Issuance Costs Paid-
Proceeds From Sale Of Common Stock In At The Market Offerings-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities34.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-106.44
Total Cash Flow7.53
4 historic quarters locked

Sign in to unlock the full Disc Medicine Inc cash flow history.

Sign In Create Free Account

About Disc Medicine Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-325034

Figures are derived from filed reports and may be restated. Historical data is subject to revision.